// App-Quantinova.ai

1070 : Anti-PSMA humanized CAR T-cell with improved persistence and resistance to tumor microenvironment for metastatic castration resistant prostate cancer (mCRPC)

Researchers

Presenter

  • Marco Della Peruta

Principal Investigators

  • Victoria Koullourou

  • Mohamed El-Kholy

  • Mathew Robson

  • Philip Wu

  • Matteo Righi

  • Mathieu Ferrari

  • Giulia Agliardi

  • James Sillibourne

  • Simon Thomas

  • Shimobi Onuoha

  • Shaun Cordoba

  • Martin Pule

Medical Centers

  • ADC Therapeutics, London, United Kingdom

  • UCL Cancer Institute, University College London,, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • Interleukin 12

Drug/Treatment

  • IL-12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved